KORU MEDICAL SYSTEMS INC (KRMD) Stock Analyst Ratings
NASDAQ:KRMD - Nasdaq - US7599101026 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to KRMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.61. This target is 51.21% above the current price.
KRMD was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about KRMD.
In the previous month the buy percentage consensus was at a similar level.
KRMD was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-01-17 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-01-14 | Lake Street | Maintains | Buy -> Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-14 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-09-07 | Lake Street | Initiate | Buy |
| 2023-09-07 | B. Riley Securities | Initiate | Buy |
| 2023-08-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-01-06 | Piper Sandler | Maintains | Overweight |
| 2022-11-10 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2022-11-10 | Piper Sandler | Upgrade | Neutral -> Overweight |